Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.18
OMCL's Cash to Debt is ranked lower than
91% of the 1887 Companies
in the Global Health Information Services industry.

( Industry Median: 10.32 vs. OMCL: 0.18 )
Ranked among companies with meaningful Cash to Debt only.
OMCL' s Cash to Debt Range Over the Past 10 Years
Min: 0.18  Med: No Debt Max: No Debt
Current: 0.18
Equity to Asset 0.45
OMCL's Equity to Asset is ranked lower than
69% of the 1730 Companies
in the Global Health Information Services industry.

( Industry Median: 0.60 vs. OMCL: 0.45 )
Ranked among companies with meaningful Equity to Asset only.
OMCL' s Equity to Asset Range Over the Past 10 Years
Min: -0.57  Med: 0.7 Max: 0.78
Current: 0.45
-0.57
0.78
Interest Coverage 8.40
OMCL's Interest Coverage is ranked lower than
81% of the 1440 Companies
in the Global Health Information Services industry.

( Industry Median: 170.89 vs. OMCL: 8.40 )
Ranked among companies with meaningful Interest Coverage only.
OMCL' s Interest Coverage Range Over the Past 10 Years
Min: 8.4  Med: 410.61 Max: 2381.5
Current: 8.4
8.4
2381.5
F-Score: 5
Z-Score: 2.67
M-Score: -2.44
WACC vs ROIC
6.46%
4.36%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 4.60
OMCL's Operating margin (%) is ranked higher than
50% of the 1829 Companies
in the Global Health Information Services industry.

( Industry Median: 4.63 vs. OMCL: 4.60 )
Ranked among companies with meaningful Operating margin (%) only.
OMCL' s Operating margin (%) Range Over the Past 10 Years
Min: 0.31  Med: 7.72 Max: 11.25
Current: 4.6
0.31
11.25
Net-margin (%) 2.36
OMCL's Net-margin (%) is ranked lower than
53% of the 1829 Companies
in the Global Health Information Services industry.

( Industry Median: 3.12 vs. OMCL: 2.36 )
Ranked among companies with meaningful Net-margin (%) only.
OMCL' s Net-margin (%) Range Over the Past 10 Years
Min: 0.21  Med: 5.73 Max: 20.32
Current: 2.36
0.21
20.32
ROE (%) 3.51
OMCL's ROE (%) is ranked lower than
56% of the 1780 Companies
in the Global Health Information Services industry.

( Industry Median: 5.57 vs. OMCL: 3.51 )
Ranked among companies with meaningful ROE (%) only.
OMCL' s ROE (%) Range Over the Past 10 Years
Min: 0.19  Med: 6.39 Max: 25.13
Current: 3.51
0.19
25.13
ROA (%) 1.97
OMCL's ROA (%) is ranked lower than
54% of the 1890 Companies
in the Global Health Information Services industry.

( Industry Median: 2.71 vs. OMCL: 1.97 )
Ranked among companies with meaningful ROA (%) only.
OMCL' s ROA (%) Range Over the Past 10 Years
Min: 0.14  Med: 4.58 Max: 17.93
Current: 1.97
0.14
17.93
ROC (Joel Greenblatt) (%) 25.85
OMCL's ROC (Joel Greenblatt) (%) is ranked higher than
53% of the 1855 Companies
in the Global Health Information Services industry.

( Industry Median: 20.90 vs. OMCL: 25.85 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
OMCL' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 2.43  Med: 49.63 Max: 91.06
Current: 25.85
2.43
91.06
Revenue Growth (3Y)(%) 12.90
OMCL's Revenue Growth (3Y)(%) is ranked higher than
72% of the 1444 Companies
in the Global Health Information Services industry.

( Industry Median: 5.00 vs. OMCL: 12.90 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
OMCL' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: -53.3  Med: 9.9 Max: 18.7
Current: 12.9
-53.3
18.7
EBITDA Growth (3Y)(%) 19.60
OMCL's EBITDA Growth (3Y)(%) is ranked higher than
71% of the 1178 Companies
in the Global Health Information Services industry.

( Industry Median: 7.90 vs. OMCL: 19.60 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
OMCL' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -13.6  Med: 19.6 Max: 121.1
Current: 19.6
-13.6
121.1
EPS Growth (3Y)(%) 21.40
OMCL's EPS Growth (3Y)(%) is ranked higher than
69% of the 1073 Companies
in the Global Health Information Services industry.

( Industry Median: 7.40 vs. OMCL: 21.40 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
OMCL' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -69.7  Med: 14.45 Max: 260.9
Current: 21.4
-69.7
260.9
» OMCL's 10-Y Financials

Financials (Next Earnings Date: Est. 2016-10-29)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow
Oprt. Cash Flow & Net Income

» Details

Guru Trades

Q3 2015

OMCL Guru Trades in Q3 2015

Jim Simons 263,443 sh (+192.71%)
Ken Fisher 554,000 sh (unchged)
Joel Greenblatt Sold Out
» More
Q4 2015

OMCL Guru Trades in Q4 2015

Paul Tudor Jones 9,900 sh (New)
Ken Fisher 554,000 sh (unchged)
Jim Simons 130,818 sh (-50.34%)
» More
Q1 2016

OMCL Guru Trades in Q1 2016

Paul Tudor Jones 17,445 sh (+76.21%)
Jim Simons Sold Out
Ken Fisher 531,000 sh (-4.15%)
» More
Q2 2016

OMCL Guru Trades in Q2 2016

Ken Fisher 536,152 sh (+0.97%)
Paul Tudor Jones Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with OMCL

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Application Software » Health Information Services
Compare:NAS:PINC, NYSE:EVH, NAS:NH, NAS:HQY, NAS:HSTM, NYSE:TDOC, NAS:WBMD, NAS:QSII, OTCPK:PMCUF, NYSE:IMPR, NAS:INOV, NAS:CPSI, NYSE:EVDY, OTCPK:ACHI, OTCPK:COGZF, OTCPK:OMCM, NAS:STRM, OTCPK:ADAT, OTCPK:CLOK, OTCPK:FBAYF » details
Traded in other countries:OC9.Germany,
Omnicell Inc provides automation & business information solutions to update medication administration process & manage costly medical supplies for operational efficiency & patient safety. Its operating business segments are acute care & non-acute care.

Omnicell Inc is a Delaware corporation incorporated in California in 1992 under the name Omnicell Technologies, Inc. and reincorporated in Delaware in 2001 as Omnicell, Inc. The Company is a provider of automation and business information solutions enabling healthcare systems to streamline the medication administration process and manage costly medical supplies for increased operational efficiency and enhanced patient safety. The Company's automation, analytics and medication adherence solutions in hospitals and longer-term care environments are designed to enable healthcare facilities to acquire, manage, dispense and administer medications and medical-surgical supplies and are intended to enhance patient safety, reduce medication errors, reduce operating costs, improve workflow, and increase operational efficiency. Approximately 6,500 hospitals, institutional pharmacies, and retail pharmacies use Company's products. The Company is organized into two operating business segments: Acute Care, which includes products and services sold to hospital customers, and Non-Acute Care, which includes products and services sold to customers outside of the hospital setting. In acute care facilities, its solutions use software‑based medication control and tracking algorithms that interact with hardware security features, resulting in a system that provides both the pharmacist and the nurse real-time safety controls. It also provides medication bar code verification at every step of the medication administration process, from entry to the hospital through the administration of the medication to a patient. Its systems enables customers to reduce or eliminate inefficiencies such as manual tracking and reconciliations, nursing time spent in obtaining medications and in performing inventory control and extraneous process steps. Similar to its medication solutions, Company's medical and surgical supply systems provide hospitals control over consumable supplies critical to providing quality healthcare. Its solutions provide inventory control software that is designed to ensure critical supplies are always stocked in the right locations. It also offers analytics and reporting software for pharmacists and material managers to more easily manage inventory flow, tracking and optimization. The Non-Acute Care segment represents products sold outside the hospital setting and includes medication adherence products sold under the brand name of MTS, and dispensing systems sold under the Omnicell brand. The MTS products consist of proprietary medication packaging systems and related products for use by institutional pharmacies servicing long-term care, and correctional facilities or retail pharmacies serving patients in their local communities. These systems use consumable medication punch cards and specialized machines that allow the pharmacies to automatically or semi-automatically assemble, fill and seal drugs into medication punch cards representing a week

Ratios

vs
industry
vs
history
P/E(ttm) 96.05
OMCL's P/E(ttm) is ranked lower than
87% of the 1206 Companies
in the Global Health Information Services industry.

( Industry Median: 24.23 vs. OMCL: 96.05 )
Ranked among companies with meaningful P/E(ttm) only.
OMCL' s P/E(ttm) Range Over the Past 10 Years
Min: 8.9  Med: 41.93 Max: 1353
Current: 96.05
8.9
1353
Forward P/E 26.18
OMCL's Forward P/E is ranked lower than
63% of the 285 Companies
in the Global Health Information Services industry.

( Industry Median: 21.51 vs. OMCL: 26.18 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 96.05
OMCL's PE(NRI) is ranked lower than
87% of the 1206 Companies
in the Global Health Information Services industry.

( Industry Median: 24.29 vs. OMCL: 96.05 )
Ranked among companies with meaningful PE(NRI) only.
OMCL' s PE(NRI) Range Over the Past 10 Years
Min: 8.9  Med: 41.93 Max: 1353
Current: 96.05
8.9
1353
Price/Owner Earnings (ttm) 146.33
OMCL's Price/Owner Earnings (ttm) is ranked lower than
92% of the 700 Companies
in the Global Health Information Services industry.

( Industry Median: 23.31 vs. OMCL: 146.33 )
Ranked among companies with meaningful Price/Owner Earnings (ttm) only.
OMCL' s Price/Owner Earnings (ttm) Range Over the Past 10 Years
Min: 7.72  Med: 32.28 Max: 3988.33
Current: 146.33
7.72
3988.33
P/B 3.26
OMCL's P/B is ranked lower than
57% of the 1682 Companies
in the Global Health Information Services industry.

( Industry Median: 2.74 vs. OMCL: 3.26 )
Ranked among companies with meaningful P/B only.
OMCL' s P/B Range Over the Past 10 Years
Min: 0.96  Med: 2.36 Max: 6.93
Current: 3.26
0.96
6.93
P/S 2.26
OMCL's P/S is ranked lower than
52% of the 1763 Companies
in the Global Health Information Services industry.

( Industry Median: 2.10 vs. OMCL: 2.26 )
Ranked among companies with meaningful P/S only.
OMCL' s P/S Range Over the Past 10 Years
Min: 0.95  Med: 2.21 Max: 4.68
Current: 2.26
0.95
4.68
PFCF 47.96
OMCL's PFCF is ranked lower than
78% of the 645 Companies
in the Global Health Information Services industry.

( Industry Median: 24.13 vs. OMCL: 47.96 )
Ranked among companies with meaningful PFCF only.
OMCL' s PFCF Range Over the Past 10 Years
Min: 7.86  Med: 31.14 Max: 2576
Current: 47.96
7.86
2576
POCF 34.37
OMCL's POCF is ranked lower than
80% of the 814 Companies
in the Global Health Information Services industry.

( Industry Median: 17.00 vs. OMCL: 34.37 )
Ranked among companies with meaningful POCF only.
OMCL' s POCF Range Over the Past 10 Years
Min: 6.85  Med: 19.8 Max: 841.67
Current: 34.37
6.85
841.67
EV-to-EBIT 55.83
OMCL's EV-to-EBIT is ranked lower than
82% of the 1177 Companies
in the Global Health Information Services industry.

( Industry Median: 16.80 vs. OMCL: 55.83 )
Ranked among companies with meaningful EV-to-EBIT only.
OMCL' s EV-to-EBIT Range Over the Past 10 Years
Min: -155.1  Med: 23.4 Max: 219.2
Current: 55.83
-155.1
219.2
EV-to-EBITDA 21.85
OMCL's EV-to-EBITDA is ranked lower than
69% of the 1271 Companies
in the Global Health Information Services industry.

( Industry Median: 12.69 vs. OMCL: 21.85 )
Ranked among companies with meaningful EV-to-EBITDA only.
OMCL' s EV-to-EBITDA Range Over the Past 10 Years
Min: 4  Med: 15.4 Max: 137.3
Current: 21.85
4
137.3
PEG 3.01
OMCL's PEG is ranked lower than
65% of the 563 Companies
in the Global Health Information Services industry.

( Industry Median: 1.90 vs. OMCL: 3.01 )
Ranked among companies with meaningful PEG only.
OMCL' s PEG Range Over the Past 10 Years
Min: 0.4  Med: 1.57 Max: 79.04
Current: 3.01
0.4
79.04
Shiller P/E 67.95
OMCL's Shiller P/E is ranked lower than
74% of the 290 Companies
in the Global Health Information Services industry.

( Industry Median: 36.95 vs. OMCL: 67.95 )
Ranked among companies with meaningful Shiller P/E only.
OMCL' s Shiller P/E Range Over the Past 10 Years
Min: 36.8  Med: 53.29 Max: 75.09
Current: 67.95
36.8
75.09
Current Ratio 1.63
OMCL's Current Ratio is ranked lower than
59% of the 1723 Companies
in the Global Health Information Services industry.

( Industry Median: 1.96 vs. OMCL: 1.63 )
Ranked among companies with meaningful Current Ratio only.
OMCL' s Current Ratio Range Over the Past 10 Years
Min: 0.64  Med: 2.41 Max: 5.21
Current: 1.63
0.64
5.21
Quick Ratio 1.25
OMCL's Quick Ratio is ranked lower than
70% of the 1723 Companies
in the Global Health Information Services industry.

( Industry Median: 1.82 vs. OMCL: 1.25 )
Ranked among companies with meaningful Quick Ratio only.
OMCL' s Quick Ratio Range Over the Past 10 Years
Min: 0.4  Med: 2.1 Max: 4.95
Current: 1.25
0.4
4.95
Days Inventory 67.16
OMCL's Days Inventory is ranked lower than
79% of the 1075 Companies
in the Global Health Information Services industry.

( Industry Median: 17.16 vs. OMCL: 67.16 )
Ranked among companies with meaningful Days Inventory only.
OMCL' s Days Inventory Range Over the Past 10 Years
Min: 35.43  Med: 54.71 Max: 77.78
Current: 67.16
35.43
77.78
Days Sales Outstanding 97.09
OMCL's Days Sales Outstanding is ranked lower than
73% of the 1430 Companies
in the Global Health Information Services industry.

( Industry Median: 67.60 vs. OMCL: 97.09 )
Ranked among companies with meaningful Days Sales Outstanding only.
OMCL' s Days Sales Outstanding Range Over the Past 10 Years
Min: 56.2  Med: 69.17 Max: 97.09
Current: 97.09
56.2
97.09
Days Payable 43.61
OMCL's Days Payable is ranked higher than
50% of the 1278 Companies
in the Global Health Information Services industry.

( Industry Median: 43.35 vs. OMCL: 43.61 )
Ranked among companies with meaningful Days Payable only.
OMCL' s Days Payable Range Over the Past 10 Years
Min: 27.77  Med: 35.76 Max: 46.45
Current: 43.61
27.77
46.45

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -2.00
OMCL's 3-Year Average Share Buyback Ratio is ranked higher than
54% of the 1148 Companies
in the Global Health Information Services industry.

( Industry Median: -2.50 vs. OMCL: -2.00 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
OMCL' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -140.8  Med: -4 Max: 1.6
Current: -2
-140.8
1.6

Valuation & Return

vs
industry
vs
history
Price/Projected FCF 1.79
OMCL's Price/Projected FCF is ranked higher than
50% of the 813 Companies
in the Global Health Information Services industry.

( Industry Median: 1.78 vs. OMCL: 1.79 )
Ranked among companies with meaningful Price/Projected FCF only.
OMCL' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.94  Med: 1.51 Max: 106.41
Current: 1.79
0.94
106.41
Price/DCF (Earnings Based) 8.98
OMCL's Price/DCF (Earnings Based) is ranked lower than
96% of the 114 Companies
in the Global Health Information Services industry.

( Industry Median: 1.43 vs. OMCL: 8.98 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.03
OMCL's Price/Median PS Value is ranked higher than
57% of the 1602 Companies
in the Global Health Information Services industry.

( Industry Median: 1.11 vs. OMCL: 1.03 )
Ranked among companies with meaningful Price/Median PS Value only.
OMCL' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.23  Med: 1.03 Max: 2.17
Current: 1.03
0.23
2.17
Price/Peter Lynch Fair Value 3.84
OMCL's Price/Peter Lynch Fair Value is ranked lower than
81% of the 336 Companies
in the Global Health Information Services industry.

( Industry Median: 1.73 vs. OMCL: 3.84 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
OMCL' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.69  Med: 1.84 Max: 46.76
Current: 3.84
0.69
46.76
Earnings Yield (Greenblatt) (%) 1.80
OMCL's Earnings Yield (Greenblatt) (%) is ranked lower than
53% of the 1823 Companies
in the Global Health Information Services industry.

( Industry Median: 2.40 vs. OMCL: 1.80 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
OMCL' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 0.5  Med: 4.2 Max: 17.7
Current: 1.8
0.5
17.7
Forward Rate of Return (Yacktman) (%) 32.82
OMCL's Forward Rate of Return (Yacktman) (%) is ranked higher than
89% of the 725 Companies
in the Global Health Information Services industry.

( Industry Median: 9.90 vs. OMCL: 32.82 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
OMCL' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: -2.6  Med: 26.7 Max: 43.8
Current: 32.82
-2.6
43.8

More Statistics

Revenue (TTM) (Mil) $599.5
EPS (TTM) $ 0.39
Beta0.65
Short Percentage of Float3.37%
52-Week Range $25.06 - 40.24
Shares Outstanding (Mil)36.16

Analyst Estimate

Dec16 Dec17 Dec18
Revenue (Mil $) 705 772 804
EPS ($) 1.43 1.87 2.08
EPS w/o NRI ($) 1.43 1.87 2.08
EPS Growth Rate
(3Y to 5Y Estimate)
N/A
Dividends Per Share ($)
» More Articles for OMCL

Headlines

Articles On GuruFocus.com
Ken Fisher's Top 5 New Portfolio Stocks Jul 27 2014 
Omnicell Inc. (OMCL) V.P., Finance & CFO Robin Gene Seim sells 1,250 Shares Feb 03 2011 
Omnicell Inc. (OMCL) President and CEO Randall A Lipps sells 11,997 Shares Jan 24 2011 
Omnicell Inc. (OMCL) President and CEO Randall A Lipps sells 11,997 Shares Jan 12 2011 
Omnicell Inc. (OMCL) President and CEO Randall A Lipps sells 937 Shares Jan 05 2011 
Omnicell Inc. (OMCL) President and CEO Randall A Lipps sells 3,351 Shares Dec 22 2010 
Omnicell Inc. (OMCL) President and CEO Randall A Lipps sells 1,500 Shares Dec 03 2010 
Omnicell Inc. (OMCL) V.P., Finance & CFO Robin Gene Seim sells 4,265 Shares Nov 30 2010 
Omnicell Inc. (OMCL) President and CEO Randall A Lipps sells 11,372 Shares Oct 22 2010 
Omnicell Inc. (OMCL) President and CEO Randall A Lipps sells 11,372 Shares Oct 08 2010 

More From Other Websites
OMNICELL, INC Financials Aug 16 2016
OMNICELL, INC Files SEC form 8-K, Other Events Aug 05 2016
Omnicell, Inc. :OMCL-US: Earnings Analysis: Q2, 2016 By the Numbers : August 3, 2016 Aug 03 2016
Omnicell (OMCL) Tops Q2 Earnings & Revenues, Margins Drag Aug 02 2016
Edited Transcript of OMCL earnings conference call or presentation 28-Jul-16 8:30pm GMT Jul 29 2016
Omnicell reports 2Q loss Jul 28 2016
Omnicell reports 2Q loss Jul 28 2016
Omnicell Selected to Provide Interoperable Medication Automation Solutions to Support Patient Safety... Jul 28 2016
Omnicell Achieves Record Revenue in the Second Quarter 2016 Jul 28 2016
Omnicell Selected to Provide Interoperable Medication Automation Solutions to Support Patient Safety... Jul 28 2016
OMNICELL, INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Jul 28 2016
Omnicell Achieves Record Revenue in the Second Quarter 2016 Jul 28 2016
Q2 2016 Omnicell Inc Earnings Release - After Market Close Jul 28 2016
Medical Information Earnings on Jul 28: DRAD, OMCL, QSII Jul 27 2016
Omnicell to Release Second Quarter 2016 Earnings Results on July 28th Jul 21 2016
Henry Mayo Newhall Hospital Selects Omnicell Medication Automation to Improve Nursing Workflows and... Jul 20 2016
ETF’s with exposure to Omnicell, Inc. : June 27, 2016 Jun 27 2016
OMNICELL, INC Files SEC form 8-K, Change in Directors or Principal Officers Jun 13 2016
Omnicell Grows amid Weak Margins, Hospital Spending Woes Jun 02 2016
OMNICELL, INC Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 25 2016

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)